218 related articles for article (PubMed ID: 29792872)
1. Association of glucocerebrosidase polymorphisms and mutations with dementia in incident Parkinson's disease.
Lunde KA; Chung J; Dalen I; Pedersen KF; Linder J; Domellöf ME; Elgh E; Macleod AD; Tzoulis C; Larsen JP; Tysnes OB; Forsgren L; Counsell CE; Alves G; Maple-Grødem J
Alzheimers Dement; 2018 Oct; 14(10):1293-1301. PubMed ID: 29792872
[TBL] [Abstract][Full Text] [Related]
2. Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort.
Winder-Rhodes SE; Evans JR; Ban M; Mason SL; Williams-Gray CH; Foltynie T; Duran R; Mencacci NE; Sawcer SJ; Barker RA
Brain; 2013 Feb; 136(Pt 2):392-9. PubMed ID: 23413260
[TBL] [Abstract][Full Text] [Related]
3. Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort.
Crosiers D; Verstraeten A; Wauters E; Engelborghs S; Peeters K; Mattheijssens M; De Deyn PP; Theuns J; Van Broeckhoven C; Cras P
Neurosci Lett; 2016 Aug; 629():160-164. PubMed ID: 27397011
[TBL] [Abstract][Full Text] [Related]
4. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X
Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366
[TBL] [Abstract][Full Text] [Related]
5. Effects of glucocerebrosidase gene polymorphisms and mutations on the risk of Parkinson's disease dementia: A meta-analysis.
Zhang Y; Chen J; Xu C; Feng J; Li J
Neurosci Lett; 2020 Jan; 714():134544. PubMed ID: 31672490
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the glucocerebrosidase gene are common in patients with Parkinson's disease from Eastern Canada.
Han F; Grimes DA; Li F; Wang T; Yu Z; Song N; Wu S; Racacho L; Bulman DE
Int J Neurosci; 2016; 126(5):415-21. PubMed ID: 26000814
[TBL] [Abstract][Full Text] [Related]
7. Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?
Goldstein O; Gana-Weisz M; Cohen-Avinoam D; Shiner T; Thaler A; Cedarbaum JM; John S; Lalioti M; Gurevich T; Bar-Shira A; Mirelman A; Giladi N; Orr-Urtreger A
Mol Genet Metab; 2019 Dec; 128(4):470-475. PubMed ID: 31662221
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.
Clark LN; Ross BM; Wang Y; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
Neurology; 2007 Sep; 69(12):1270-7. PubMed ID: 17875915
[TBL] [Abstract][Full Text] [Related]
9. Features of
Malek N; Weil RS; Bresner C; Lawton MA; Grosset KA; Tan M; Bajaj N; Barker RA; Burn DJ; Foltynie T; Hardy J; Wood NW; Ben-Shlomo Y; Williams NW; Grosset DG; Morris HR;
J Neurol Neurosurg Psychiatry; 2018 Jul; 89(7):702-709. PubMed ID: 29378790
[TBL] [Abstract][Full Text] [Related]
10. Survival and dementia in GBA-associated Parkinson's disease: The mutation matters.
Cilia R; Tunesi S; Marotta G; Cereda E; Siri C; Tesei S; Zecchinelli AL; Canesi M; Mariani CB; Meucci N; Sacilotto G; Zini M; Barichella M; Magnani C; Duga S; Asselta R; Soldà G; Seresini A; Seia M; Pezzoli G; Goldwurm S
Ann Neurol; 2016 Nov; 80(5):662-673. PubMed ID: 27632223
[TBL] [Abstract][Full Text] [Related]
11. Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia.
Blauwendraat C; Reed X; Krohn L; Heilbron K; Bandres-Ciga S; Tan M; Gibbs JR; Hernandez DG; Kumaran R; Langston R; Bonet-Ponce L; Alcalay RN; Hassin-Baer S; Greenbaum L; Iwaki H; Leonard HL; Grenn FP; Ruskey JA; Sabir M; Ahmed S; Makarious MB; Pihlstrøm L; Toft M; van Hilten JJ; Marinus J; Schulte C; Brockmann K; Sharma M; Siitonen A; Majamaa K; Eerola-Rautio J; Tienari PJ; ; Pantelyat A; Hillis AE; Dawson TM; Rosenthal LS; Albert MS; Resnick SM; Ferrucci L; Morris CM; Pletnikova O; Troncoso J; Grosset D; Lesage S; Corvol JC; Brice A; Noyce AJ; Masliah E; Wood N; Hardy J; Shulman LM; Jankovic J; Shulman JM; Heutink P; Gasser T; Cannon P; Scholz SW; Morris H; Cookson MR; Nalls MA; Gan-Or Z; Singleton AB
Brain; 2020 Jan; 143(1):234-248. PubMed ID: 31755958
[TBL] [Abstract][Full Text] [Related]
12. [The clinical features of Parkinson's disease in patients with mutations and polymorphic variants of GBA gene].
Senkevich KA; Miliukhina IV; Beletskaia MV; Gracheva EV; Kudrevatykh AV; Nikolaev MA; Emelyanov AK; Kopytova AE; Timofeeva AA; Yakimovskii AF; Pchelina SN
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):81-86. PubMed ID: 29171494
[TBL] [Abstract][Full Text] [Related]
13. The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal.
Berge-Seidl V; Pihlstrøm L; Maple-Grødem J; Forsgren L; Linder J; Larsen JP; Tysnes OB; Toft M
Neurosci Lett; 2017 Sep; 658():48-52. PubMed ID: 28830825
[TBL] [Abstract][Full Text] [Related]
14. Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease.
Davis MY; Johnson CO; Leverenz JB; Weintraub D; Trojanowski JQ; Chen-Plotkin A; Van Deerlin VM; Quinn JF; Chung KA; Peterson-Hiller AL; Rosenthal LS; Dawson TM; Albert MS; Goldman JG; Stebbins GT; Bernard B; Wszolek ZK; Ross OA; Dickson DW; Eidelberg D; Mattis PJ; Niethammer M; Yearout D; Hu SC; Cholerton BA; Smith M; Mata IF; Montine TJ; Edwards KL; Zabetian CP
JAMA Neurol; 2016 Oct; 73(10):1217-1224. PubMed ID: 27571329
[TBL] [Abstract][Full Text] [Related]
15. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease.
Neumann J; Bras J; Deas E; O'Sullivan SS; Parkkinen L; Lachmann RH; Li A; Holton J; Guerreiro R; Paudel R; Segarane B; Singleton A; Lees A; Hardy J; Houlden H; Revesz T; Wood NW
Brain; 2009 Jul; 132(Pt 7):1783-94. PubMed ID: 19286695
[TBL] [Abstract][Full Text] [Related]
16. Glucocerebrosidase variant T369M is not a risk factor for Parkinson's disease in Sweden.
Ran C; Brodin L; Gellhaar S; Westerlund M; Fardell C; Nissbrandt H; Söderkvist P; Sydow O; Markaki I; Hertz E; Wirdefeldt K; Svenningsson P
Neurosci Lett; 2022 Jul; 784():136767. PubMed ID: 35779693
[TBL] [Abstract][Full Text] [Related]
17. Contribution of glucocerebrosidase mutation in a large cohort of sporadic Parkinson's disease in Taiwan.
Huang CL; Wu-Chou YH; Lai SC; Chang HC; Yeh TH; Weng YH; Chen RS; Huang YZ; Lu CS
Eur J Neurol; 2011 Oct; 18(10):1227-32. PubMed ID: 21338444
[TBL] [Abstract][Full Text] [Related]
18. β-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson's disease.
Moraitou M; Hadjigeorgiou G; Monopolis I; Dardiotis E; Bozi M; Vassilatis D; Vilageliu L; Grinberg D; Xiromerisiou G; Stefanis L; Michelakakis H
Mol Genet Metab; 2011; 104(1-2):149-52. PubMed ID: 21745757
[TBL] [Abstract][Full Text] [Related]
19. Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden.
Ran C; Brodin L; Forsgren L; Westerlund M; Ramezani M; Gellhaar S; Xiang F; Fardell C; Nissbrandt H; Söderkvist P; Puschmann A; Ygland E; Olson L; Willows T; Johansson A; Sydow O; Wirdefeldt K; Galter D; Svenningsson P; Belin AC
Neurobiol Aging; 2016 Sep; 45():212.e5-212.e11. PubMed ID: 27255555
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.
Aharon-Peretz J; Rosenbaum H; Gershoni-Baruch R
N Engl J Med; 2004 Nov; 351(19):1972-7. PubMed ID: 15525722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
